GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Odyssey Health Inc (OTCPK:ODYY) » Definitions » Operating Cash Flow per Share

ODYY (Odyssey Health) Operating Cash Flow per Share : $-0.01 (TTM As of Jan. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Odyssey Health Operating Cash Flow per Share?

Odyssey Health's operating cash flow per share for the three months ended in Jan. 2025 was $0.00. Odyssey Health's operating cash flow per share for the trailing twelve months (TTM) ended in Jan. 2025 was $-0.01.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 29.40% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -41.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Odyssey Health's Operating Cash Flow per Share or its related term are showing as below:

ODYY' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -233.2   Med: -64.15   Max: 29.4
Current: 29.4

During the past 10 years, Odyssey Health's highest 3-Year average Operating Cash Flow per Share Growth Rate was 29.40% per year. The lowest was -233.20% per year. And the median was -64.15% per year.

ODYY's 3-Year OCF Growth Rate is ranked better than
76.76% of 697 companies
in the Medical Devices & Instruments industry
Industry Median: 8.2 vs ODYY: 29.40

Odyssey Health Operating Cash Flow per Share Historical Data

The historical data trend for Odyssey Health's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Odyssey Health Operating Cash Flow per Share Chart

Odyssey Health Annual Data
Trend Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.04 -0.04 -0.02 -0.01

Odyssey Health Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 - - - -

Competitive Comparison of Odyssey Health's Operating Cash Flow per Share

For the Medical Devices subindustry, Odyssey Health's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Odyssey Health's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Odyssey Health's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Odyssey Health's Price-to-Operating-Cash-Flow falls into.


;
;

Odyssey Health Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Odyssey Health's Operating Cash Flow per Share for the fiscal year that ended in Jul. 2024 is calculated as

Operating Cash Flow per Share (A: Jul. 2024 )=Cash Flow from Operations (A: Jul. 2024 )/Shares Outstanding (Diluted Average) (A: Jul. 2024 )
=-1.215/97.064
=-0.01

Odyssey Health's Operating Cash Flow per Share for the quarter that ended in Jul. 2024 is calculated as

Operating Cash Flow per Share (Q: Jan. 2025 )=Cash Flow from Operations (Q: Jan. 2025 )/Shares Outstanding (Diluted Average) (Q: Jan. 2025 )
=-0.047/104.710
=-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Odyssey Health Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Odyssey Health's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Odyssey Health Business Description

Traded in Other Exchanges
N/A
Address
2300 West Sahara Avenue, Suite 800 - No. 4012, Las Vegas, NV, USA, 89102
Odyssey Health Inc is a developing medical and pharmaceutical technology that solves unmet clinical needs and has a substantial market opportunity. Its medical devices include CardioMap and Save-A-Life.
Executives
Erik C. Emerson other: Chief Commercial Officer 2300 WEST SAHARA AVENUE, SUITE 800 - #4012, LAS VEGAS NV 89102
Gregory W Gironda other: Chief Operating Officer 2300 WEST SAHARA AVENUE, SUITE 800 - #4012, LAS VEGAS NV 89102
Ricky Richardson director 2372 MORSE AVE., IRVINE CA 92614
Christine Farrell officer: Controller/Secretary 2372 MORSE AVE, IRVINE CA 92614
John P Gandolfo director 62 TERRACE ROAD, WAYNE NJ 07470
Jerome H Casey director 2372 MORSE AVE, IRVINE CA 92614
Jeffrey X Conroy director 2372 MORSE AVE, IRVINE CA 92614
Vanlandingham Jacob Ph.d director 2372 MORSE AVE, IRVINE CA 92614
J Michael Redmond director, officer: President/CEO 10 CANTERBURY ROAD, WINDHAM NH 03087